ZOLL Medical Corporation on Tuesday announced a definitive agreement to acquire Cardiac Science Corporation (CSC), a portfolio company of Aurora Resurgence, a Los Angeles-based private equity investment firm, for an undisclosed value.
With executive offices in Deerfield, Wisconsin, Cardiac Science Corporation (CSC) is leading provider of automated external defibrillators (AEDs), related services and accessories.
The company said sudden cardiac arrest (SCA), an abrupt disruption of the heart's function, which causes a lack of blood flow to vital organs, claims more than 350,000 lives each year in the US. If a victim does not receive CPR and early defibrillation from an AED, chances of survival decrease 10% with each passing minute.
ZOLL's lifesaving AED management programme technology reportedly enables dispatchers to communicate the locations of registered AEDs to callers reporting potential sudden cardiac arrest incidents.
Hence, Cardiac Science's addition to ZOLL's AED Link programme will allow more 9-1-1 agencies to help put AEDs in the hands of laypersons and first responders to support life-saving action.
ZOLL Medical develops and markets medical devices and software solutions to advance emergency care and save lives and part of Asahi Kasei Group company.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon